Hologic Can't Ban Rival's Surgical Devices After Fed. Circ. Win
The Federal Circuit on Wednesday refused to grant Hologic Inc.'s request to block a rival from infringing a patent for its endometrial ablation treatment NovaSure, even as it affirmed a $5 million...To view the full article, register now.
Already a subscriber? Click here to view full article